Diane Gosselin

WORK HISTORY

EDUCATION

SKILLS

ABOUT DIANE GOSSELIN

I have been passionately committed to the financing of biomedical R&D for over 30 years. President and Chief Executive Officer of CQDM between 2012 and 2025, I joined the organization in 2008 as Vice-President, Research and Business Development where I have been actively involved in the creation of CQDM. I have demonstrated the relevance and the value of CQDM’s model in building an impressive portfolio of 150 outstanding technologies that strongly impact biopharmaceutical research and mobilizes more than 120 SMEs. I have raised $375M in funding at CQDM and I have developed several local and international partnerships that have generated another $225M to further support innovative R&D across Canada.Prior to CQDM, I have worked at the Fonds de solidarité FTQ where I managed an investment portfolio and helped several companies implement their drug development strategy. At PROCREA BioSciences, I led the research team that developed the first worldwide non-invasive diagnostic test for endometriosis. I took part in several Life Sciences matters, notably as a member of focus groups, investment Committees, and as a Board member of 15 organizations. I am currently member of the Board of CQDM and CATALIS.I hold a Ph.D. in microbiology and immunology from Université de Montréal, as well as an Executive MBA from Université du Québec à Montréal (UQAM) and Université Paris-Dauphine. Also, I have completed the certification Corporate Governance from Université suis passionnément engagée dans le financement de la R&D biomédicale depuis plus de 30 ans. Présidente-directrice générale du CQDM entre 2012 et 2025, j’ai joint l\'organisation en 2008 à titre de vice-présidente, Recherche et développement des affaires où j\'ai participé activement à la création du CQDM. J\'ai démontré la pertinence et la valeur du modèle du CQDM en construisant un impressionnant portefeuille de 150 technologies exceptionnelles qui ont un fort impact sur la recherche biopharmaceutique et qui mobilisent plus de 120 PME. J\'ai levé 375 millions de dollars de fonds au CQDM et j\'ai développé plusieurs partenariats locaux et internationaux qui ont généré 225 millions de dollars supplémentaires pour soutenir la R&D innovante à travers le Canada.Avant le CQDM, j\'ai travaillé au Fonds de solidarité FTQ où j\'ai géré un portefeuille d\'investissements et aidé plusieurs entreprises à mettre en œuvre leur stratégie de développement de médicaments. Chez PROCREA BioSciences, j\'ai dirigé l\'équipe de recherche qui a mis au point le premier test diagnostique non invasif pour l\'endométriose.